Good Housekeeping: When will kids get COVID-19 vaccines? Experts share a timeline to keep in mind
UC expert says COVID-19 vaccines for kids could be ready this spring
Good Housekeeping turned to Carl Fichtenbaum, MD, of the UC College of Medicine Division of Infectious Diseases as an expert source for a story on when parents can expect to see COVID-19 vaccines available for their young children. COVID-19 vaccination trials for adolescents between the ages of 12 and 15 and younger children are well underway. Early results suggest vaccines could be 100% effective in younger teens, according to new reports.
Carl Fichtenbaum, MD, of the UC College of Medicine Division of Infectious Diseases/Photo/Colleen Kelley/UC Creative + Brand
Fichtenbaum said enrollment periods for the necessary safety trials in children may already be full for the Moderna and Pfizer vaccines specifically.
"Because both manufacturers have fully enrolled their numbers of children from 12 to 16, it should be soon that they'd accumulate the antibody data and preliminary information on efficacy," Fichtenbaum says. "I would expect that Pfizer may submit for a summertime emergency use authorization (EUA) at the latest; Moderna enrolled about 3,000 children between 12 and 18 in February, so I would expect a similar timeline."
Fichtenbaum says that any company seeking approval for vaccine use in children will be looking to collect data through "Day 57," if not longer: "Once they've reached that point in time, they'll be able to go to the FDA... Bottom line is that Pfizer's EUA application may come quite soon, as they have the data. Moderna may look closer to May or early June."
Fichtenbaum was also interviewed by WCPO-TV on why it is important for college students to get vaccinated for COVID-19. See that coverage here.
Lead image/NNDanko
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.
What is squalane, and how does it work to moisturize skin?
October 27, 2025
The University of Cincinnati's Kelly Dobos was featured in a Women's Health article discussing squalane, an ingredient being increasingly used in moisturizing skincare products.